|Articles|June 1, 1999

Supplements and Featured Publications

  • Clinical and Economic Impact of Breast Cancer Treatment and Prevention in High-Risk Women
  • Volume 5
  • Issue 6 Suppl

Question-and-Answer Session

Download PDF: Question-and-Answer Session

Articles in this issue

over 26 years ago

The Economics and Challenges of Breast Cancer in a Managed Care Environment

over 26 years ago

Participating Faculty

over 26 years ago

Medical and Economic Impact of Breast Cancer Treatment and Prevention

over 26 years ago

Benefits Foregone: Too Much of the Wrong and Too Little of the Right

over 26 years ago

Breast Cancer: Overview of Current Management Considerations of Economic Impact

over 26 years ago

Breast Cancer Epidemiology: An Overview

over 26 years ago

Overview of Cancer Economics

over 26 years ago

Breast Cancer Stage Cost Analysis in a Managed Care Population

over 26 years ago

The Cost Effectiveness of Tamoxifen in the Prevention of Breast Cancer

over 26 years ago

Selected Abstracts

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs
Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

View more
Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care
AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

View more
Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text